Makito Miyake, Nobutaka Nishimura, Yuki Oda, Tatsuki Miyamoto, Mitsuru Tomizawa, Takuto Shimizu, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, et al. Dysgeusia in patients with advanced urothelial carcinoma receiving enfortumab vedotin, platinum-based chemotherapy, or immune check point inhibitors: time-course assessment using chemotherapy-induced taste alteration scale. Journal of chemotherapy (Florence, Italy). 2024. 1-13
Yusuke Iemura, Makito Miyake, Shinji Fukui, Tomomi Fujii, Sayuri Ohnishi, Shunta Hori, Yosuke Morizawa, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, et al. Depth of invasion to the bladder wall as a prognostic factor and its association with circulating cell-free DNA levels in patients with muscle-invasive bladder cancer. Current urology. 2023. 17. 4. 229-235
Makito Miyake, Nobutaka Nishimura, Yuichi Nishioka, Tomomi Fujii, Yuki Oda, Tatsuki Miyamoto, Mitsuru Tomizawa, Takuto Shimizu, Takuya Owari, Kenta Ohnishi, et al. Clinical impact of the intensity of follow-up cystoscopy in patients with high-risk non-muscle-invasive bladder cancer. International Urology and Nephrology. 2023
Kazumasa Torimoto, Tomohiro Ueda, Daisuke Gotoh, Kuniyuki Kano, Makito Miyake, Yasushi Nakai, Shunta Hori, Yosuke Morizawa, Kenta Onishi, Takuto Shimizu, et al. Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study. Lower urinary tract symptoms. 2023
Yasushi Nakai, Nobumichi Tanaka, Isao Asakawa, Shunta Hori, Makito Miyake, Kaori Yamaki, Satoshi Anai, Kazumasa Torimoto, Takeshi Inoue, Masatoshi Hasegawa, et al. Quality of life in patients who underwent robot-assisted radical prostatectomy compared with those who underwent low-dose-rate brachytherapy. The Prostate. 2023. 83. 7. 701-712